-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Allarity Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Allarity Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.37M, a 18.9% increase year-over-year.
- Allarity Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$16.9M, a 11.6% increase year-over-year.
- Allarity Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$17.1M, a 50.3% increase from 2022.
- Allarity Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$34.5M, a 29.8% decline from 2021.
- Allarity Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$26.6M, a 219% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)